| [1] |
European Association for the Study of the Liver. EASL clinical practice guidelines: vascular diseases of the liver[J]. J Hepatol, 2016, 64(1): 179-202.
|
| [2] |
Northup PG, Garcia-Pagan JC, Garcia-Tsao G, et al. Vascular liver disorders, portal vein thrombosis, and procedural bleeding in patients with liver disease: 2020 practice guidance by the American association for the study of liver diseases[J]. Hepatology, 2021, 73(1): 366-413.
|
| [3] |
中华医学会消化病学分会肝胆疾病分组. 肝硬化门静脉血栓管理专家共识（2020年,上海）[J]. 临床肝胆病杂志, 2020, 36(12): 2667-2674.
|
| [4] |
Rajani R, Björnsson E, Bergquist A, et al. The epidemiology and clinical features of portal vein thrombosis: A multicentre study[J]. Aliment Pharmacol Ther, 2010, 32(9): 1154-1162.
|
| [5] |
Tsochatzis EA, Senzolo M, Germani G, et al. Systematic review: portal vein thrombosis in cirrhosis[J]. Aliment Pharmacol Ther, 2010, 31(3): 366-374.
|
| [6] |
Violi F, Corazza GR, Caldwell SH, et al. Incidence and recurrence of portal vein thrombosis in cirrhotic patients[J]. Thromb Haemost, 2019, 119(3): 496-499.
|
| [7] |
Ponziani FR, Zocco MA, Senzolo M, et al. Portal vein thrombosis and liver transplantation: implications for waiting list period, surgical approach, early and late follow-up[J]. Transpl Rev(Orlando), 2014, 28(2): 92-101.
|
| [8] |
Rodriguez-Castro KI, Porte RJ, Nadal E, et al. Management of nonneoplastic portal vein thrombosis in the setting of liver transplantation: A systematic review[J]. Transplantation, 2012, 94(11): 1145-1153.
|
| [9] |
Nery F, Chevret S, Condat B, et al. Causes and consequences of portal vein thrombosis in 1,243 patients with cirrhosis: results of a longitudinal study[J]. Hepatology, 2015, 61(2): 660-667.
|
| [10] |
Francoz C, Valla D, Durand F. Portal vein thrombosis, cirrhosis, and liver transplantation[J]. J Hepatol, 2012, 57(1): 203-212.
|
| [11] |
La Mura V, Tripodi A, Tosetti G, et al. Resistance to thrombomodulin is associated with de novo portal vein thrombosis and low survival in patients with cirrhosis[J]. Liver Int, 2016, 36(9): 1322-1330.
|
| [12] |
Saugel B, Lee M, Feichtinger S, et al. Thrombophilic factor analysis in cirrhotic patients with portal vein thrombosis[J]. J Thromb Thrombol, 2015, 40(1): 54-60.
|
| [13] |
Queck A, Carnevale R, Uschner FE, et al. Role of portal venous platelet activation in patients with decompensated cirrhosis and TIPS[J]. Gut, 2020, 69(8): 1535-1536.
|
| [14] |
Xing Y, Tian Y, Jiang Y, et al. A practical nomogram based on systemic inflammatory markers for predicting portal vein thrombosis in patients with liver cirrhosis[J]. Ann Med, 2022, 54(1): 302-309.
|
| [15] |
Yerdel MA, Gunson B, Mirza D, et al. Portal vein thrombosis in adults undergoing liver transplantation: risk factors, screening, management, and outcome[J]. Transplantation, 2000, 69(9): 1873-1881.
|
| [16] |
Sherman CB, Behr S, Dodge JL, et al. Distinguishing tumor from bland portal vein thrombus in liver transplant candidates with hepatocellular carcinoma: the A-VENA criteria[J]. Liver Transpl, 2019, 25(2): 207-216.
|
| [17] |
Giri S, Singh A, Kolhe K, et al. Natural history of portal vein thrombosis in cirrhosis: A systematic review with meta-analysis[J]. J Gastroenterol Hepatol, 2023, 38(10): 1710-1717.
|
| [18] |
Senzolo M, Sartori TM, Rossetto V, et al. Prospective evaluation of anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis[J]. Liver Int, 2012, 32(6): 919-927.
|
| [19] |
Zhang Y, Xu BY, Wang XB, et al. Prevalence and clinical significance of portal vein thrombosis in patients with cirrhosis and acute decompensation[J]. Clin Gastroenterol Hepatol, 2020, 18(11): 2564-2572, e1.
|
| [20] |
Maruyama H, Okugawa H, Takahashi M, et al. De novo portal vein thrombosis in virus-related cirrhosis: predictive factors and long-term outcomes[J]. Am J Gastroenterol, 2013, 108(4): 568-574.
|
| [21] |
Amitrano L, Guardascione MA, Martino R, et al. Hypoxic hepatitis occurring in cirrhosis after variceal bleeding: still a lethal disease[J]. J Clin Gastroenterol, 2012, 46(7): 608-612.
|
| [22] |
Zanetto A, Rodriguez-Kastro KI, Germani G, et al. Mortality in liver transplant recipients with portal vein thrombosis- an updated meta-analysis[J]. Transpl Int, 2018, 31(12): 1318-1329.
|
| [23] |
Lisman Ton. Treatment of portal vein thrombosis in cirrhosis with anticoagulation--more than meets the eye?[J]. Hepatobiliary Surg Nutr, 2024, 13(2): 321-324.
|
| [24] |
Rodriguez-Castro KI, Vitale A, Fadin M, et al. A prediction model for successful anticoagulation in cirrhotic portal vein thrombosis[J]. Eur J Gastroenterol Hepatol, 2019, 31(1): 34-42.
|
| [25] |
Simonetto DA, Singal AK, Garcia-Tsao G, et al. ACG clinical guideline: disorders of the hepatic and mesenteric circulation[J]. Am J Gastroenterol, 2020, 115(1): 18-40.
|
| [26] |
Rodríguez-Castro KI, Senzolo M, Sartori MT. Optimal length of anticoagulant therapy in cirrhotic patients with portal vein thrombosis[J]. Clin Gastroenterol Hepatol, 2012, 10(7): 820-821.
|
| [27] |
Cui SB, Shu RH, Yan SP, et al. Efficacy and safety of anticoagulation therapy with different doses of enoxaparin for portal vein thrombosis in cirrhotic patients with hepatitis B[J]. Eur J Gastroenterol Hepatol, 2015, 27(8): 914-919.
|
| [28] |
Lobo B, Finch C, Howard A, et al. Fondaparinux for the treatment of patients with acute heparin-induced thrombocytopenia[J]. Thromb Haemost, 2008, 99(1): 208-214.
|
| [29] |
Loffredo L, Pastori D, Farcomeni A, et al. Effects of anticoagulants in patients with cirrhosis and portal vein thrombosis: A systematic review and meta-analysis[J]. Gastroenterology, 2017, 153(2): 480-487, e1.
|
| [30] |
La Mura V, Braham S, Tosetti G, et al. Harmful and beneficial effects of anticoagulants in patients with cirrhosis and portal vein thrombosis[J]. Clin Gastroenterol Hepatol, 2018, 16(7): 1146-1152, e4.
|
| [31] |
Leader A, Ten Cate V, Ten Cate-Hoek AJ, et al. Anticoagulation in thrombocytopenic patients with hematological malignancy: A multinational clinical vignette-based experiment[J]. Eur J Intern Med, 2020, 77: 86-96.
|
| [32] |
Rodrigues SG, Sixt S, Abraldes JG, et al. Systematic review with meta-analysis: portal vein recanalisation and transjugular intrahepatic portosystemic shunt for portal vein thrombosis[J]. Aliment Pharmacol Ther, 2019, 49(1): 20-30.
|
| [33] |
Bianchini M, Cavani G, Bonaccorso A, et al. Low molecular weight heparin does not increase bleeding and mortality post-endoscopic variceal band ligation in cirrhotic patients[J]. Liver Int, 2018, 38(7): 1253-1262.
|